title: Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
abstract: An H-2Kb- negative clone of BL6 melanoma (BL6-8) was transfected with neor, H-2Kb, or H-2IAk genes. In an 18-h cytotoxicity assay clones with high levels of H-2Kb Ag expression were found more sensitive to lysis by spleen cells of syngenic and allogeneic mice than H-2Kb low clones. NK cells were involved in the lysis of H-2Kb+ BL6 melanoma clones, with spleen cell cytotoxicity of mice increased after poly I:C stimulation or decreased after pretreatment with anti-asialo GM1 serum or NK1.1 mAb. Anti-TNF Ab were also able to reduce the cytotoxicity of normal spleen cells and completely abolished the cytotoxicity of the NK-depleted spleen cells suggesting involvement of NC cells in lysis of H-2Kb+ BL6 melanoma clones. Increase in sensitivity of H-2Kb+ BL6 cells to natural cell-mediated cytotoxicity was associated with the appearance of NK recognizable determinants as assessed by the cold target inhibition assay. All BL6 clones, irrespective of sensitivity to natural cell-mediated cytotoxicity, showed high sensitivity to lysis by LGL-derived granules. In contrast, all H-2Kb low BL6 clones were resistant and all H-2Kb highly positive clones were sensitive to lysis by TNF-alpha. When an H-2Kb highly positive clone was selected in vitro for resistance to TNF, it concomitantly showed increased resistance to cytotoxicity by spleen cells, confirming the importance of TNF in spleen cell cytotoxicity against H-2Kb+ melanoma cells. Taken together, the data indicate that class I H-2Kb but not class II H-2IAk gene product could increase the sensitivity of BL6 cells to lysis by NK and natural cytotoxic cells as well as TNF. We hypothesize that these effects could be due to pleiotropic effects of H-2Kb gene products on various biologic properties of BL6 melanoma cells some of which may be more directly involved in regulation of tumor cell sensitivity to lysis by NK and/or natural cytotoxic cells.
authors.affiliation: Pittsburgh Cancer Institute, Department of Pathology, University of Pittsburgh, PA 15213.
authors.forename: E
authors.initials: E
authors.lastname: Gorelik
authors.forename: G
authors.initials: G
authors.lastname: Jay
authors.forename: B
authors.initials: B
authors.lastname: Kwiatkowski
authors.forename: R B
authors.initials: RB
authors.lastname: Herberman
mesh_terms: D000367:Age Factors; D000818:Animals; D015550:Cell Degranulation; D003602:Cytotoxicity, Immunologic; D005434:Flow Cytometry; D006183:H-2 Antigens / Q000235:genetics*; D000949:Histocompatibility Antigens Class II / Q000235:genetics; D007111:Immunity, Cellular; D007694:Killer Cells, Natural / Q000276:immunology; D008285:Major Histocompatibility Complex; D008546:Melanoma, Experimental / Q000276:immunology*; D051379:Mice; D008815:Mice, Inbred Strains; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
chemical_list: D006183:H-2 Antigens; D000949:Histocompatibility Antigens Class II; D014409:Tumor Necrosis Factor-alpha